Eight-year-old Yonatan Moshe Erlichman, who was featured in a 2020 Israeli commercial promoting COVID-19 vaccinations for children, died last month of sudden cardiac arrest. Israel, a “lab for Pfizer,” showed a significant myocarditis safety signal soon after introducing the shots.

Yonatan Moshe Erlichman, the son and grandson of prominent Israeli doctors, almost drowned in the bathtub after his heart stopped on the eve of Yom Kippur. Although paramedics were able to revive him, he died several days later on Sept. 28.

In 2020, Erlichman appeared in a video with Shuski, described as a “friendly puppet ‘child,’” urging viewers to get the COVID-19 vaccine when it became available.

Describing Erlichman as the “poster child” for Israel’s vaccine campaign, LifeSiteNews shared the government-sponsored video featuring the boy, released just prior to the introduction of the COVID-19 vaccines in Israel.

Here is a partial translation of the tweet (via Google Translate):

“Doesn’t that shock you? Where are the headlines? The investigations? How many more children will die on the golden altar?

“And in particular, there are already two controlled studies that show that the mRNA vaccines cause cardiac problems … How much more will you deny?

“Remember that at any given moment, this can happen to your beloved children and grandchildren.”

Another tweet questioned why the story was not on televised news, but only in local and religious press. The person reported that the family was “scared to death and were trying to keep the story quiet.”

The boy’s family released the following statement:

“Our Yonatan Moshe passed away a short time ago. On the eve of Yom Kippur, Yonatan went into cardiac arrest in our home, and since then we fought by his side after he collapsed. We thank all those dear to us who were by our side in the last days of his life.”

Netanyahu bragged about making Israel a ‘lab for Pfizer’

Israel is one of the most mRNA-vaccinated countries on Earth, with more than 70% of its people over 16 receiving at least two doses by April 2021.

In November 2020, Israel’s government signed an agreement with Pfizer to acquire 8 million doses of its COVID-19 vaccine, which the government began distributing in December 2020.

In exchange for receiving the vaccine ahead of other countries, Israel agreed to provide Pfizer with epidemiological data to help the vaccine maker evaluate the efficacy and reactogenicity of the vaccine.

Israeli Prime Minister Benjamin Netanyahu said he was able to make Israel “the lab for Pfizer” because “98% of our population has digitized medical records” that would — when combined with his country’s “genetic database” — facilitate granular reporting of the vaccine’s impact on the country’s citizens.

With this data, “you can create a biotechnological industry that is unheard of … unimagined even,” he said.

 

Dr. Sabine Hazan, a gastroenterology specialist in Ventura, California, weighed in on Netanyahu’s Pfizer deal:

 

In light of Erlichman’s death and echoing Hazan’s tweet, Dr. Robert Malone last week expressed concern that a combined genetic and medical database could aid the development of bioweapons capable of targeting specific ethnic groups.

He noted that “the engineered SARS-CoV-2 virus appears to be more severe with specific populations that have more ACE2 receptors on their cell surfaces” and asked, “Was this a bioweapon?”

CDC failed to publicize 2021 Israeli myocarditis data in a timely manner

Information provided to Children’s Health Defense (CHD) last year by the Centers for Disease Control and Prevention (CDC) following a Freedom of Information Act request showed the CDC received a report in February 2021 about post-injection myocarditis from the Israel Ministry of Health.

The report stated, “We are seeing a large number of myocarditis and pericarditis cases in young individuals soon after Pfizer COVID-19 vaccine. We would like to discuss the issue with a relevant expert at CDC.”

Even though a significant myocarditis safety signal was visible both in the U.S. and Israel just months after the COVID-19 vaccines were made available, the CDC failed to alert the public until May 2021, after half the eligible U.S. population had already received the vaccine.

In June 2021, Israel released an official report confirming mRNA-related myocarditis in young men, especially those ages 16-24, who showed a rate of up to 25 times higher than typically observed in the Hadassah Medical Center.

A September 2022 Israeli study found the incidence of myocarditis within 30 days of the second Pfizer shot was 2.35 times higher than in the unvaccinated, with the risk for males ages 16-19 presenting as nearly 1 in 1,000.

Although the Israeli study was quick to point out that the risk of myocarditis was milder after the third Pfizer (first booster) shot, Dr. Peter McCullough warned last week at a hearing of the Novel Coronavirus Southwestern Intergovernmental Committee in the Arizona Senate that the effects of post-vaccine myocarditis can be delayed for years.

After summarizing the science around the spike protein’s effect on the heart, including reports from post-injection autopsies, McCullough related the story of an athlete who died during a heart stress test two years after being vaccinated.

[…]

Via https://childrenshealthdefense.org/defender/yonatan-moshe-erlichman-cardiac-death/?utm_id=20231024